Form 4 for MGNX MACROGENICS INC
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-15 · accession 0001125345-25-000029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-19 | 2025-02-15 | MGNX | Eck Stephen L. | Chief Medical Off | M - OptEx | $0.00 | +16.7K | 34.3K | +94% | $0 |
| D | 2025-02-19 | 2025-02-15 | MGNX | Eck Stephen L. | Chief Medical Off | F - Tax | $2.56 | -4,942 | 29.4K | -14% | -$12.7K |
| D | 2025-02-19 | 2025-02-15 | MGNX | Eck Stephen L. | Chief Medical Off | M - OptEx | $0.00 | -16.7K | 16.7K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-15 | M | A | 16,665 | $0.00 | 34,319 | D | — | — | (F1) On February 15, 2023, the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2025-02-15 | F | D | 4,942 | $2.56 | 29,377 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2025-02-15 | M | D | 16,665 | $0.00 | 16,665 | D | $0.00 · — to — | 16,665 Common Stock | (F1) On February 15, 2023, the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. |